138 related articles for article (PubMed ID: 33053421)
21. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
[TBL] [Abstract][Full Text] [Related]
22. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
23. A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population.
Wang MY; He J; Zhu ML; Teng XY; Li QX; Sun MH; Wang XF; Yang YJ; Wang JC; Jin L; Wang YN; Wei QY
Sci Rep; 2016 Jan; 6():20008. PubMed ID: 26818920
[TBL] [Abstract][Full Text] [Related]
24. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
Díaz-Serrano A; Angulo B; Dominguez C; Pazo-Cid R; Salud A; Jiménez-Fonseca P; Leon A; Galan MC; Alsina M; Rivera F; Plaza JC; Paz-Ares L; Lopez-Rios F; Gómez-Martín C
Oncologist; 2018 Sep; 23(9):1092-1102. PubMed ID: 29700210
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
26. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W
Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441
[TBL] [Abstract][Full Text] [Related]
27. Apigetrin induces extrinsic apoptosis, autophagy and G2/M phase cell cycle arrest through PI3K/AKT/mTOR pathway in AGS human gastric cancer cell.
Kim SM; Vetrivel P; Ha SE; Kim HH; Kim JA; Kim GS
J Nutr Biochem; 2020 Sep; 83():108427. PubMed ID: 32559585
[TBL] [Abstract][Full Text] [Related]
28. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway.
Rong L; Li Z; Leng X; Li H; Ma Y; Chen Y; Song F
Biomed Pharmacother; 2020 Feb; 122():109726. PubMed ID: 31918283
[TBL] [Abstract][Full Text] [Related]
29. Procyanidin B2 induces apoptosis and autophagy in gastric cancer cells by inhibiting Akt/mTOR signaling pathway.
Li Y; Lu X; Tian P; Wang K; Shi J
BMC Complement Med Ther; 2021 Feb; 21(1):76. PubMed ID: 33627124
[TBL] [Abstract][Full Text] [Related]
30. Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population.
He J; Wang MY; Qiu LX; Zhu ML; Shi TY; Zhou XY; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Li J; Yu HP; Wei QY
Mol Carcinog; 2013 Nov; 52 Suppl 1():E70-9. PubMed ID: 23423739
[TBL] [Abstract][Full Text] [Related]
31. A steroidal saponin isolated from Allium chinense simultaneously induces apoptosis and autophagy by modulating the PI3K/Akt/mTOR signaling pathway in human gastric adenocarcinoma.
Xu J; Zhang M; Lin X; Wang Y; He X
Steroids; 2020 Sep; 161():108672. PubMed ID: 32485185
[TBL] [Abstract][Full Text] [Related]
32. Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
Cheng L; Qiu L; Zhang R; Qian D; Wang M; Sun M; Zhu X; Wang Y; Guo W; Wei Q
Int J Cancer; 2019 Jan; 144(2):251-262. PubMed ID: 29978580
[TBL] [Abstract][Full Text] [Related]
33. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling.
Wang K; Liu R; Li J; Mao J; Lei Y; Wu J; Zeng J; Zhang T; Wu H; Chen L; Huang C; Wei Y
Autophagy; 2011 Sep; 7(9):966-78. PubMed ID: 21610320
[TBL] [Abstract][Full Text] [Related]
34. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
35. Pectolinarigenin Induced Cell Cycle Arrest, Autophagy, and Apoptosis in Gastric Cancer Cell via PI3K/AKT/mTOR Signaling Pathway.
Lee HJ; Venkatarame Gowda Saralamma V; Kim SM; Ha SE; Raha S; Lee WS; Kim EH; Lee SJ; Heo JD; Kim GS
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096805
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals.
Li H; He C; Wang X; Wang H; Nan G; Fang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788
[TBL] [Abstract][Full Text] [Related]
37. Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.
Li Q; Yang J; Yu Q; Wu H; Liu B; Xiong H; Hu G; Zhao J; Yuan X; Liao Z
Clin Cancer Res; 2013 Nov; 19(22):6252-60. PubMed ID: 24077347
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
[TBL] [Abstract][Full Text] [Related]
39. Anticancer effects of Lanostane against human gastric cancer cells involves autophagy, apoptosis and modulation of m-TOR/PI3K/AKT signalling pathway.
Peng X; Ruan C; Lei C; He A; Wang X; Luo R; Cai Y; Dong W; Lin J
J BUON; 2020; 25(3):1463-1468. PubMed ID: 32862591
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
